Catalyst Investments

Long term partners for growth, supporting Israeli Technology since 1999

CATALYST INVESTMENTS

Long term partners for growth, supporting Israeli Technology since 1999

About Catalyst Investments

Catalyst is a leading Israeli multi-fund firm with years of experience in investment and value creation in companies at all stages of development. Catalyst typically invests in disruptive technology companies with an Israel nexus, who are focused on long-term growth and international expansion.

Catalyst provides unique value-add to its portfolio companies – including a network of high calibre investors in markets across the US, Europe, China and Emerging-Markets, significant business networks and vast transactional experience in global capital markets and cross border M&A.

0
Founded
0
Funds
0
300 AuM ($ million)
0 +
50+ Exits from associated Partners
0
Languages spoken

About Catalyst Investments

Catalyst is a leading Israeli multi-fund firm with years of experience in investment and value creation in companies at all stages of development. Catalyst typically invests in disruptive  technology companies with an Israel nexus, who are focused on long-term growth and international expansion.

Catalyst provides unique value-add to its portfolio companies – including a network of high calibre investors in markets across the US, Europe, China and Emerging-Markets, significant business networks and vast transactional experience in global capital markets and cross border M&A.

0
Founded
0
Funds
0 +
50+ Exits from associated Partners
0
300 AuM ($ million)
0
Languages Spoken

“Catalyst leverages unparalleled access to Israeli deal-flow and global based network of partners, investors and strategic relationships across Israel, Europe, the US and China”.

Yair Shamir, Catalyst Founding and Managing Partner

Former Minister of Agriculture and Rural Development for the Government of Israel, and Member of Knesset.

“Catalyst leverages its unparalleled access to Israeli deal flow and global based network of partners, investors and strategic relationships across Israel, Europe, the US and China”. 

Yair Shamir, Catalyst Founding and Managing Partner

Former Minister of Agriculture and Rural Development for the Government of Israel, and Member of Knesset.

Our Funds

Catalyst Fund L.P.

1999

Established in 1999, Catalyst’s first fund provided venture capital to maturing Israeli technology investments and had a diversified portfolio across multiple sectors.

Catalyst Fund II L.P.

2006

Catalyst’s second fund was established in 2006. The investment strategy focused on growth-stage investment opportunities across a range of different sectors.

Catalyst-CEL Fund

2014

Catalyst’s third fund was founded in 2014. With our Hong-Kong based partner, Catalyst CEL is investing in mature disruptive Israeli technology companies and assisting with their expansion into Greater China.

Our Funds

Catalyst Fund L.P.

1999

Established in 1999, Catalyst’s first fund was a venture capital fund that focused on maturing Israeli technology investments.

Catalyst Fund II L.P.

2006

Catalyst’s second fund was established in 2006, moving away from VC investing and placing a stronger focus on growth stage investment opportunities. Prominent exits: Mobileye’s IPO on NYSE.

Catalyst-CEL Fund

2014

Catalyst’s third fund was founded in 2014. With our Hong-Kong based partner, Catalyst CEL is investing in mature disruptive Israeli technology companies and assisting with their expansion into Greater China.

Our Selected Portfolio Companies

“Catalyst aims to support capital and long-term growth of mature Israeli and Israeli-related innovative companies.

We use our knowledge, experience and network to invest sensibly, support value creation within our its portfolio companies and generate maximum returns for investors.”

Edouard Cukierman, Catalyst Founding and Managing Partner

Founder of Cukierman & Co. Investment House

“Catalyst aims to support capital and long-term growth of mature Israeli and Israeli-related innovative companies.

We use our knowledge, experience and network to invest sensibly, support value creation within our its portfolio companies and generate maximum returns for investors.”

Edouard Cukierman, Catalyst Founding and Managing Partner

Founder of Cukierman & Co. Investment House

Our Values

Leverage principals’ intimate knowledge of Israel Hi-Tech space

Unmatched experience and knowhow of the Israeli Hi-Tech eco-system built up over many decades

Broad sector focus – covering disruptors across multiple industry sub-sectors, including different stages of the life-cycle

Actively support Portfolio Companies as partners to create sustainable value for all our stakeholders

Aim to be a global point of reference for the Israeli investment world

Draw investors from around the world to discover select opportunities and to invest in Israel

Attract top international talent with broad professional expertise from leading global financial centres to work in the Israel investment space

Organise GoforIsrael conferences both in Israel and abroad, showcasing Israeli investment opportunities to   top-tier international investors

Utilise International Partnerships to add value and expand horizons

International network notably in Asia, America and Europe to help Israeli companies develop their global activities

Deep and lasting relationships – with international institutions strengthening Israel’s financial partners 

Cross-border transactional experience including commercial agreements, M&A and Capital Market transactions across multiple territories

Our Team

Our Success

Our Success

Investment Strategy

Whilst each of Catalyst’s investment vehicles has its own specific investment thesis, all of our Funds have a strong focus on identifying Israeli and Israeli-related companies that require a capital injection, strategic guidance and the right partner in order to develop and expand their business.

We look across a wide range of sectors for disruptive and defendable technology with applications in global markets. No less importantly, we invest in people, and look to partner with highly capable and motivated management teams.

We are long term investors seeking to support management teams to shape the future of their business. Our managing partners typically serve on the boards of our portfolio companies and are proactively involved in helping companies realize their full potential. Our portfolio companies benefit from the vast transactional experience of our firm its wide-reaching global networks.

Our 20 Years of History

  •  

    In 2019, Tufin successfully completed its Initial Public Offering and is now traded on the NYSE.

     

  • In 2018, Eloxx merged with a shell company and got uplisted on the Nasdaq Stock Exchange.

  • In 2017, Catalyst invested in Eloxx Pharmaceuticals, a company that develops treatments for rare genetic diseases such as Cystic Fibrosis and Cystinosis.

Catalyst vertical

Follow us

Catalyst Investments L.P.

  • Address:28, Haarbaa St., Tel Aviv 6473925, Israel
  • Phone: +972 3-695-0666

Catalyst CEL Fund

Catalyst Investments L.P.

  • Address:28, Haarbaa St., Tel Aviv 6473925, Israel
  • Phone: +972 3-695-0666

Catalyst CEL Fund

Close Menu
Catalyst_LOGO@2x

Catalyst Fund I was established in 1999 as a venture capital fund. The Fund focused its investment strategy on maturing Israeli technology companies and had a diversified portfolio across many sectors such as Telecom, Information Technology, Medical Devices and Biotechnology Sectors.

Catalyst Fund I was founded in 1999, in cooperation with the European industrial and financial group OTTO and other well-known European investors from the UK, Germany, Greece and Israel, including HSBC, OBC, M.M. Warburg & Co., Quest Group and the Union Bank of Israel.

Catalyst Investments

The Catalyst Fund II was established in 2006 and was largely focused on growth-stage investments. The fund mainly invested in Israeli public and private companies in sectors such as Technology Media and Telecom, Information Technology, Enterprise Software, Cyber Security and others.

The Fund was founded in cooperation with the European industrial and financial group OTTO, the Dassault Group, Credit Agricole, Soparexo, Credit Suisse, and other well-known international investors from France, UK, Greece, Australia and Israel.

Catalyst CEL

In 2014 Catalyst established its third vehicle, and the first Israel-China Fund, the Catalyst CEL Fund. The Fund invests in mid-to-late stage Israeli companies with proven innovation and global potential, whose strategy is oriented towards growth of activities in emerging markets with a special focus on Greater China. The Fund is jointly managed by Catalyst and by China Everbright Limited, “CEL” (HK:165), the HK listed subsidiary of China Everbright Group.

Catalyst_LOGO@2x

Catalyst Fund I was established in 1999 as a venture capital fund. The Fund focused its investment strategy on maturing Israeli technology companies and had a diversified portfolio across many sectors such as Telecom, Information Technology, Medical Devices and Biotechnology Sectors.

Catalyst Fund I was founded in 1999, in cooperation with the European industrial and financial group OTTO and other well-known European investors from the UK, Germany, Greece and Israel, including HSBC, OBC, M.M. Warburg & Co., Quest Group and the Union Bank of Israel.

Catalyst Investments

The Catalyst Fund II was established in 2006 and was largely focused on growth-stage investments. The fund mainly invested in Israeli public and private companies in sectors such as Technology Media and Telecom, Information Technology, Enterprise Software, Cyber Security and others.

The Fund was founded in cooperation with the European industrial and financial group OTTO, the Dassault Group, Credit Agricole, Soparexo, Credit Suisse, and other well-known international investors from France, UK, Greece, Australia and Israel.

Catalyst CEL

In 2014 Catalyst established its third vehicle, and the first Israel-China Fund, the Catalyst CEL Fund. The Fund invests in mid-to-late stage Israeli companies with proven innovation and global potential, whose strategy is oriented towards growth of activities in emerging markets with a special focus on Greater China. The Fund is jointly managed by Catalyst and by China Everbright Limited, “CEL” (HK:165), the HK listed subsidiary of China Everbright Group.

Established in 1999, Mobileye is a leading provider of Advanced Driver Assistant Systems (ADAS) technologies using only one camera, located inside the vehicle. Mobileye’s EyeQ vision system-on-a-chip (SoC) represents a technological breakthrough that allows consolidation of multiple applications on a single platform and is positioned to revolutionize the implementation of driver assistance systems on a mass scale. Catalyst was the only Israeli fund that invested in Mobileye and held a seat on the Board of Directors. Mobileye successfully completed a successful IPO on the NYSE in 2014 in what was the largest ever Israeli IPO, and later went on to be acquired in March 2017 by Intel for $15.3 billion, in the largest acquisition of an Israeli company in history.

More info 

Tufin Software Technologies (NYSE: TUFN) is a market leader in Security Policy Orchestrations solutions that automate and accelerate network configuration changes while maintaining security and compliance. Tufin’s award winning Orchestration Suite gives IT organizations the power and agility to enforce security policy across complex, multi-vendor enterprise networks. With more than 2,000 customers worldwide, Tufin provides policy-based automation to help customers implement changes rapidly, saving time and valuable resources, whilst maintaining continuous compliance with industry regulations and internal policies. Tufin has offices in United States, EMEA and Asia-Pacific and works with over 600 channel partners throughout the world. In April 2019, Tufin completed its IPO on the NYSE.

More info 

Established in 1996, Dori Media is an international group of media companies, with presence in Israel, Switzerland, Argentina and the Philippines. The group produces and distributes TV and new media content, broadcasts various TV channels and operates video-content internet sites. The group’s library includes, amongst others, ~7,500 episodes and more than 10,000 3-minute clips. Their catalogue contains weekly and daily series, reality and entertainment formats and kids programs that are sold to a wide variety of audiences in more than 100 countries. Dori Media notably distributes award winning Israeli show “Be’Tipul” (In Treatment) that was produced locally in 18 different territories and became the #5 format in the world in numbers of local versions that were produced.

More info 

Omrix Biopharmaceuticals was a marketing stage biotechnology company that developed and marketed Quixil, a novel biodegradable human plasma derived protein used as haemostat to control blood losses in surgery, as well as a suite of biological immunological drugs – specialized IVIGs. The Quixil, Omrix’s leading product, became the first human plasma based surgical sealant to be licensed in the United Kingdom in 1999 and received FDA approval in the U.S. in 2003. In April 2006, Omrix successfully completed its IPO on the NASDAQ and in 2008, was acquired by Johnson & Johnson.

taboola 4

Founded in 2007, Taboola is an Israeli-founded, U.S. headquartered discovery platform. Taboola’s tools enable over 1.4 billion people to discover content across the globe. Powered by Deep Learning, AI, and a large dataset, Taboola’s platform creates new monetization, audience and engagement opportunities for digital properties, including publishers, mobile carriers and handset manufacturers. Advertisers use Taboola to reach their target audience when they are most receptive to new messages, products and services.

Taboola counts global leading digital publishes amongst its clients, including CNBC, NBC News, USA TODAY, BILD, Sankei, Huffington Post, Microsoft, Business Insider, The Independent, and Le Figaro. Taboola has offices in Los Angeles, Mexico City, São Paulo, London, Berlin, Madrid, Paris, Tel Aviv, New Delhi, Bangkok, Beijing, Shanghai, Istanbul, Seoul, Tokyo, and Sydney.

More info 

xjet3

Founded in 2005 and located in Rehovot Israel, Xjet develops and manufactures the world’s first direct 3D metal and ceramics jetting system, using patented Nano Metal and Ceramic Jetting technology. The company develops both printing devices and dedicated inks and aims to redefine and lead the ceramic and metal Additive Manufacturing (AM) markets by leveraging its disruptive technology to bring high-resolution 3D output for diverse applications. The firm addresses a vast market with multi-billion-dollar opportunities across a wide range of industry verticals including aerospace, automotive, dental and many others. Xjet was founded by Hanan Gothait, an inkjet printing industry veteran who co-founded Objet Geometries, which later merged with Stratasys.

More info 

orexm

Founded in 1996, Orex developed and marketed automatic computed radiography (CR) systems for portal imaging, bringing the full benefits of film-less x-ray acquisition, management and archiving to radiotherapy departments and clinics. Following successful penetration into the global dental market, the company expanded its markets and product lines to serve medical clinics. Orex was headquartered in Yokneam, Israel, with U.S. headquarters in Auburndale, Massachusetts. In 2005, Kodak completed the acquisition of Orex, which became a wholly owned subsidiary operating within Kodak’s Health Group.

lamina4

Lamina is an innovative producer of high-quality carbide cutting tools, made from state-of-the-art submicron grades and proprietary PVD and CVD coatings. The Company is known as a global pioneer of a ground-breaking technological concept resulting in cutting tools having exceptional performance, simplifying the cutting process, decreasing costs, minimising downtime and increasing efficiency. Key product lines include Turning, Milling, Parting, Drilling and Threading. The Company serves a broad range of industrial end-markets such as Mold & Die, Machine Building, Oil & Gas as well as sophisticated industrial segments such as Power Generation and Aerospace. Headquartered in Switzerland, Lamina operates commercial subsidiaries across Europe, Asia, Latin America and North America, serving customers in over 65 countries.

More info 

elloxp

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX), founded in 2013, is a clinical stage biopharmaceutical company developing novel RNA-modulating drug candidates that are designed to treat rare and ultra-rare genetic diseases caused by premature termination codons nonsense mutations. The Company has unique solutions which addresses the unmet needs of patients that today have no alternative solutions. The firm has an experienced management team with an impressive track record in the orphan drug space as well as an impressive list of existing investors. The Company has been listed on the NASDAQ since April 2018 after it completed an underwritten public offering. The Company’s headquarters are in Waltham, Massachusetts with R&D operations in Rehovot, Israel.

More info 

satixp

Established in 2011, SatixFy Limited is a highly advanced fabless semiconductor company designing a unique system-on-chip that significantly enhance satellite ground equipment performance, lowering costs, and allowing a broader audience to enjoy a large variety of applications via satellite. The Company has a vastly experienced management team and is well-positioned to dominate the market with its unique integrated, end-to-end solution approach. Satixfy has already won key customers in major up-and-coming segments, thus achieving an early leader status.

More info